A better pathway between science and health
MR Longevity exists to shorten the distance between what science discovers and what people can actually benefit from.
Our Approach
Healthy longevity is not a single lever. Seven interacting dimensions surround every individual, each measurable, each modifiable, none sufficient alone.
CONCENTRIC MAP · 7 DIMENSIONS · ONE PERSON
Longevity is a systems challenge
Human ageing is not driven by a single mechanism. It emerges through the interaction of biology, metabolism, immunity, lifestyle, environment, psychological wellbeing and social factors.
Yet the knowledge and capabilities needed to address healthy longevity remain fragmented across research institutions, healthcare, biotechnology, diagnostics, nutrition, technology, traditional health systems and public health.
MR Longevity exists to connect these pieces.
We are building an integrated environment where different disciplines, organisations and perspectives can contribute to a shared goal: helping people live healthier for longer.
From reductionism to systems thinking
Modern biomedicine has transformed our understanding of ageing through molecular biology, genetics, biomarkers, multi-omics, clinical research and increasingly sophisticated therapeutics.
These capabilities provide the scientific precision needed to understand and intervene in biological ageing.
At the same time, healthy longevity requires us to look beyond individual molecules, diseases or interventions and understand the person as an interconnected system.
Bridging knowledge systems
We believe valuable insights can emerge from different medical and scientific traditions, but they must be examined through rigorous evidence.
MR Longevity creates a framework in which modern biomedical science can interact with established approaches to preventive and holistic health, including perspectives originating from Eastern health traditions.
The objective is not to replace evidence-based medicine. It is to investigate, validate and translate potentially valuable knowledge using modern scientific methods.
Biomarkers, multi-omics, clinical studies, real-world evidence and AI can help determine what works, for whom, under what conditions and through which biological mechanisms.
From isolated interventions to personalised longevity
There is unlikely to be a single intervention capable of solving ageing.
Healthy longevity may instead require coordinated strategies addressing multiple dimensions of health:
- Cellular & Molecular Biology, Understanding the mechanisms and hallmarks of ageing.
- Metabolic & Physiological Health, Maintaining metabolic, cardiovascular, immune and systemic resilience.
- Movement & Physical Capacity, Protecting strength, mobility, cardiovascular fitness and functional independence.
- Nutrition, Supporting metabolic health and physiological function.
- Sleep & Recovery, Supporting repair, neurological health and biological regulation.
- Mental & Social Wellbeing, Recognising the relationship between psychological health, social connection and biological ageing.
- Environment & Behaviour, Understanding how everyday exposures and behaviours influence long-term health.
The goal is not simply to add years to life. It is to preserve health, capability and quality of life throughout those years.
From Knowledge to Evidence to Impact
MR Longevity is designed as a translation mission.
SCIENCE → DISCOVERY → VALIDATION → TRANSLATION → PERSONALISED HEALTH → REAL-WORLD OUTCOMES
At the centre sits: DATA + AI
Data generated through research, diagnostics, clinical practice and real-world outcomes can continuously return to the mission. This creates a learning cycle:
Science → People → Data → Better Science
Over time, this can help researchers identify new questions, clinicians make better-informed decisions, innovators develop better solutions and individuals receive increasingly personalised approaches to healthy longevity.
Our Principle
Open to ideas. Rigorous about evidence.
MR Longevity is designed to encourage scientific exploration without confusing possibility with proof.
Emerging discoveries, traditional knowledge, new technologies and novel interventions should be explored. But their evidence must also be transparent.
That means distinguishing between each level of certainty:
This principle allows MR Longevity to remain ambitious about what may become possible while maintaining scientific credibility about what is known today.
- 0125%
Hypothesis
Open to ideas
- 0250%
Emerging Evidence
Signals, early data
- 0375%
Clinical Evidence
Trials, replication
- 04100%
Validated Practice
Rigorous about proof
What We Are Building
MR Longevity is more than a longevity information platform. It is an emerging global translation mission connecting:
Science
researchers, universities and discoveries
Healthcare
clinicians, diagnostics and personalised prevention
Innovation
biotechnology, health technology and AI
Industry
development, manufacturing and commercialisation
Capital
investors and strategic partners
Public Health
prevention and population-scale healthy ageing
People
the ultimate beneficiaries and participants
Data + AI
the intelligence layer connecting and improving the mission
One mission. One shared direction.
- Understand ageing better.
- Detect change earlier.
- Prevent disease where possible.
- Translate discoveries faster.
- Personalise health more intelligently.
- Help people remain healthier for longer.
Founded by Professor Daniel Qiang Fu 付强
Longevity scientist and biotech entrepreneur working across cellular senescence, geroscience, regenerative medicine and longevity biotechnology, with a peer-reviewed publication record, granted patents and nationally funded research programmes.
See the founder's research recordWho is MR Longevity for?
Researchers, clinicians, innovators, investors, international partners, public-health organisations and individuals who want to live healthier for longer.
Join MR Longevity